UBS Live - Solutions

Date
Thursday 17 February 2022
Time
11:00am to 12:30pm SGT

Q1 Client fund summit

Positioning for higher inflation and rising rates

Speakers


Kelvin Tay

Regional Chief Investment Officer UBS Global Wealth Management

Kelvin Tay is the Regional Chief Investment Officer at UBS Global Wealth Management. 

Kelvin is a member of the UBS Global Emerging Markets Investment Committee, as well as the Asia-Pacific Investment Committee where he provides strategic research and inputs to the investment and asset allocation process across asset classes.

Based in Singapore, Kelvin joined UBS Global Wealth Management Asia in April 2006 and was deputy head of P&S Consulting (Southeast Asia), where he helped clients structure investment portfolios based on asset allocation. Prior to joining UBS, Kelvin worked at Deutsche Bank Private Wealth Management (Asia) as the Asian & European Equity Strategist responsible for Asian & European equity selection. He was also the portfolio manager of the Asian equities portfolio and was also responsible for conducting funds research.

From 2002 to 2004, Kelvin was a Regional Telecoms Analyst with JPMorgan Chase where he was consistently one of the top 3 rated regional Asian telecoms analysts in international surveys such as AsiaMoney and Institutional Investor.

From 2000 to 2002, Kelvin was a Regional Telecoms Analyst with ABN AMRO (Asia) Ltd in Hong Kong, where he was ranked No.3 in AsiaMoney's Asia-wide regional telecoms analyst survey in 2001 and his team was ranked No. 1 in the 2000 Greenwich survey. Prior to that, Kelvin worked at Overseas Union Bank in Singapore as a credit analyst in loan syndications and capital markets.

Benjamin Tai

Portfolio manager and Senior Analyst Blackrock

Benjamin Tai, CFA, Director, is a portfolio manager and senior analyst with the Global Real Asset Securities Group with 15 years of investment experience.

His responsibilities include covering real estate and infrastructure securities in the Asia-Pacific region. Prior to joining Blackrock, Benjamin worked at Norges Bank Investment Management in both Singapore and London as the primary analyst for Asia Pacific real estate securities. Preceding that, Benjamin worked at UBS AG in Hong Kong as a sell side equity analyst in global listed real estate strategy, and before that at Macquarie Bank in Sydney as an analyst for the global property securities fund. Benjamin graduated with a Bachelor of Commerce degree from the University of New South Wales. He is a Chartered Financial Analyst charterholder.

Sean Connor

President of Blue Owl Securities and Managing Director of Blue Owl Capital

Sean Connor is President of Blue Owl Securities and a Managing Director of Blue Owl Capital, and before that Owl Rock Capital.

Sean joined Blue Owl in 2016 as one of its first employees. Sean is at the forefront of Blue Owl’s initiative to bring its investment platform to the private wealth space, with a focus on fund structuring, formation and capital raising. Sean serves on various Blue Owl operating committees and chairs its product group. In 2020, Sean was recognized by Private Debt Investor as one of the industry’s Rising Stars, a list of 40 individuals under the age of 40 with the potential to shape the future of the private debt asset class.

Prior to joining Blue Owl, Sean served as a Managing Director of CION Investment Management. Sean was a member of CION’s Investment Committee and responsible for overseeing all aspects of CION’s business, including its non-traded BDC that was sub-advised by an affiliate of Apollo Global Management. Prior to joining CION, Sean held roles focusing on originating, underwriting, negotiating and corporate finance transactions globally. Sean received a B.A. in Economics from Columbia University. Sean maintains Series 7, 63 and 24 registrations.

Brad Brezinski

Head of International Relationship Management

CPM Boston Partners (Robeco’s U.S. asset management subsidiary)

Mr. Brezinski is the Head of International Relationship Management responsible for the business development and marketing strategy outside North America.

Prior to this role, he was responsible for international business development as a product specialist for Boston Partners, Robeco’s U.S. asset management subsidiary. He rejoined the firm after a brief period in 2013 with Tenor Capital Management as an operations and investor relations associate. Before that, Mr. Brezinski had joined the firm in 2010 as an RFP writer in the Marketing department, which supported all of the firm’s equity strategies. Previously, he also worked in the wealth management department at Merrill Lynch where he supported an advisory team that served high net worth clients.

John Bradshaw

Senior Portfolio Manager UBS O’Connor

John Bradshaw is the Senior Portfolio Manager for the Asian Long/Short strategy.

John joined O’Connor in April 2012, prior to this he worked at UBS Investment Bank running the Asian Tactical Trading strategy for the segregated proprietary trading team called “The Fundamental Investment Group” from 2005 to 2012. Most of this time was spent in Hong Kong before moving to Singapore in 2011. From 2001 to 2005, he was the Head of the Cash Equity Trading team for UBS Investment Bank which involved facilitating client business, trading a proprietary trading book as well as managing a team of seven professionals across Hong Kong/London and New York. Prior to his move to Hong Kong in 2001, he was based in London as a UK Equity Trader. John has over 27 years of investment experience, has three A level examinations and joined SG Warburg in 1991 direct from school into their training program.

Agenda

Time

Time

Segment

Segment

Time

11:00am

Segment

Opening Remarks

Patricia Quek, Business Sector Head, Singapore, Malaysia & GFIM

UBS Global Wealth Management

Time

11:05am – 11:20am

Segment

CIO Updates

Kelvin Tay

Regional Chief Investment Officer

UBS Global Wealth Management

Time

11:20am - 11:35am

Segment

Income – alternative yield (public assets)

Benjamin Tai, Portfolio Manager and Senior Analyst

BGF Global Real Asset Securities

Time

11:35am-

11:50am

Segment

Income – alternative yield (private assets)

Sean Connor, President of Blue Owl Securities and a Managing Director of Blue Owl Capital,

Owl Rock Technology Income Corp

Time

11:50am – 12:10pm

 

Segment

Value Rotation

Brad Brezinski, Head International Relationship Management

CPM Boston Partners (Robeco’s U.S. asset management subsidiary)

Time

12:10pm –

12:20pm

Segment

Alternative Strategies

John Bradshaw, Managing Director, Senior Portfolio Manager,

UBS O’Connor

Time

12:20pm –

12:35pm

Segment

Q&A Session moderated by Paul Stefansson

Managing Director, Investment Funds & Alternatives, UBS Global Wealth Management

We want to hear from you


1. How satisfied are you with UBS webinars overall?
Please select 1 radio button

2. What can we do to improve your webinar experience?

3. Which topics are you most interested?
Please select at least 1 checkbox

Watch our important series

Previously on UBS Live

UBS MY Way: Meet the future of Portfolio Management

01 November 2021

Read more

Climate and environment philanthropy: collective giving

22 April 2021

Read more

Investing in the Year of the Metal Ox

24 February 2021

Read more

Tigers and Art: The economic, social demographic, and consumer context for the art and luxury market in Southeast Asia

29 January 2021

Read more

Women series

Mid-year Outlook 2021

Healthcare Summit 2021

Opening address

Read more

Keynote address

Ageing is a disease, and that disease is treatable. In extraordinary times like this, a health crisis that puts almost everything in jeopardy has also renewed our perspective on the true meaning of longevity. With COVID-19 vaccines being developed at breakneck speeds, we remain cautiously optimistic about the future of healthcare. How has advancements in preventive health, target treatment and healthtech paved the way for the next decade and beyond? While we are already living longer, can we also live better?

Read more

Future of preventive care

It has been more than a year since the COVID-19 pandemic brought the world to a grinding halt. Vaccines are developed and inoculated at breakneck speeds. What protection does the vaccine have against variants of the virus? Why are Asian countries lagging in vaccine rollouts and what is the lasting impact of the pandemic?

Read more

Future of personalised medicine

Is personalised treatment & healthcare the way forward?
How far have we come in treatment that uses therapy that targets specific genes and proteins for cancer patients? What are the tools that are making drug discovery and development more efficient and predictable? How would precision medicine shape the future in oncology therapeutics?

Read more

Future of healthtech

What new care models are emerging to push telemedicine beyond mere virtualisation?
What models have successfully crossed borders and have become scalable in multiple geographies?

Read more

Sustainable Finance Conference 2021